TLPH Talphera Inc.

$TLPH I'm still not loving this chart action. It says to anticipate another delay when earnings are announced on Nov. 11.

$TLPH $CRMD Interesting timing for Niyad. Oct. 21: Fresenius announces the U.S. launch of its new multiFiltratePRO CKRT system, featuring integrated citrate anticoagulation. Nov. 11: FMC hosts a webinar explaining why citrate is preferred over heparin, specifically addressing remaining contraindications and whether citrate is suitable for ALL patients. FMC is clearly investing in citrate adoption. That’s competition for Niyad, but also highlights its opportunity in patients where citrate is unsuitable. The key question: Can Niyad capture that unmet need and compete on simplicity?

$TLPH Nafamostat vs Heparin: * Published October 20, 2026. * Liver study at a Chinese hospital. * Nafamostat: 60 patients; Heparin: 62 patients. * Patients had acute-on-chronic liver failure. * Circuit anticoagulation: Nafamostat 91.7%; Heparin 90.3% * Patients with bleeding: Nafamostat 3.3%; Heparin 19.4% * Patients with adverse events: Nafamostat 36.7%; Heparin 58.1% * Nafamostat: Less disruption of systemic coagulation

$TLPH took about 5 months to enroll 25% from 50% to 75%. That is without having all the clinical sites activated. Now that all sites are activated and per tlph hardest part is behind them. Its clear to predict that it will take less than 5 months to enroll the rest 25% Projected completion window based on 2.5–4 months from the 75% announcement (August 12, 2026): • 2.5 months → approximately October 27, 2026 • 3 months → approximately November 12, 2026 • 3.5 months → approximately November 27, 2026 • 4 months → approximately December 12, 2026

$TLPH just by looking at the history. Prediction is that nothing will be announced for the month of October and November. It will be a party time for shorties. Buckle up

$TLPH its very bizarre to have this much unawareness. There was never a drug like this that has so much potential but already been established for decades with safety and effectiveness. Essentially zero risk. Yet no spotlight or share price that matches the value. Unless im missing something, this stock could be once in a lifetime investment opportunity.

$TLPH Brunoez, when it comes to predicting time, Vince is perhaps the worst. In every conference and presentation he exaggerates the timeline, while knowing he is exaggerating. But, other than exaggerating timelines, he is doing everything right. He had the presence of mind to acquire Niyad before any other pharma got to do it. That was brilliant. Furthermore, show me one person that doesn't exaggerate abilities, and I'll show you a mythical creature.

$TLPH Nowhere in my post did I point fingers or even mention Vince's name, so I'm not really sure why you are making that association. As for timing, the last 18 patients took 23 weeks. If the rate stays the same, that would mean the final 17 patients would take 21-22 weeks = January. However, he did imply that the rate was increasing and he keeps mentioning the end of the year, so December is definitely in play.

$TLPH What could Vince do that he is not already doing? Pointing fingers is easy. It would be very normal for enrollment to drag to mid-February. Highly unlikely it takes a day longer. The hope for ending in a couple of months is just that, hope. It's possible, but not a sure thing. February is a sure thing.

$TLPH The trading volume for the past 8 days adds up to the lowest total for any 8 day period since July, 2025. Seems very strange to me considering how close to completion we are. I'm also still trying to figure out why the market is placing a lower value on the company now vs. a few months ago.

$TLPH yesterday before opening i put in order at 1.06 for 8k shares. Only a lousy 13 shares filled. I am pissed. Will I get another chance on my gtc order.

$TLPH Today marks 9 weeks since the announcement of 75% enrollment. If the previous rate of .78 patients/week still holds, 9 x .78 = 7 more enrollees, which puts us at 60 total. At worst, that leaves 13 more weeks at this rate of enrollment = Jan 13, 2027.

$TLPH This is what concerned me about the technicals. I see this is a failure of management (looking at you, Vince) to instill confidence that he'll ever get the study completed. Literally every time they come out with an update, it's to announce another delay. At this point, I believe they will not have it done by the end of the year.

$TLPH does the stock price of tlph have a floor under it. Just curious because both same ceo that seems to not care about share holder value. I own 43,500 share. More than I should in one stock.